NEUROBiOGEN

본문 바로가기 주메뉴 바로가기

Comunications

NEUROBIOGEN has been working with an advisory network of researchers and clinical
experts specializing in brain & neurological diseases with long experience.

News

News
Notice

News

Here are news on NEUROBIOGEN (currently in Korean only).

NO	SUBJECT	DATE	VIEW
99	"Wigobi there"...BioVenture Speeds Research on Native Obesity Drugs.	2024. 03. 26	364
98	Kim Sang-wook, CEO of Neurobiogen, said, "We will promote the transfer of technology and treatment for dementia and obesity".	2024. 03. 20	407
97	Neurobiogen "Phase 1 successful treatment for obesity and dementia...Application for Phase 2 of Q2".	2024. 03. 20	413
96	Neurobiogen, obesity treatment..."It's more effective and safer" than the mainstream GLP-1.	2024. 03. 20	380
95	Neurobiogen Succeeds in Phase 1 Clinical Trials for Dementia and Obesity Drugs..."Nothing is wrong with financing".	2024. 03. 20	391
94	Neurobiogen "Succeeds in Phase 1 Clinical Trials for Native Obesity Drugs..."Preparing for the 2nd Global Prize".	2024. 03. 20	376
93	Neurobiogen "Innovative Dementia and Obesity Treatment Phase 1 Successful..."Promoting joint development with global pharmaceutical companies".	2024. 03. 20	385
92	Neurobiogen 'Clinical Phase 1 Termination'...Proposing a New Paradigm for the Treatment of Dementia and Obesity.	2024. 03. 20	347
91	Neurobiogen "Confirms Safety in Phase 1 Clinical Trials for Native Obesity Drugs..."Look forward to winning the 2nd prize".	2024. 03. 20	385
90	[Life magazine's great day] Modern people's chronic disease, obesity! How can I get out of this?	2024. 02. 08	351

1 2 3 4 5